alexa
Reach Us +44-1522-440391
Hao-Yu Zheng | OMICS International
ISSN: 2161-1165

Epidemiology: Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Hao-Yu Zheng

Taiwan
Publications

Down-Regulation of MutS Homolog 2 (MSH2) Expression by Curcumin Enhances Cytotoxicity Induced by Gemcitabine in Human Lung Adenocarcinoma Cells

Gemcitabine (2′,2′-difluorodeoxycytidine) is a difluorinated analog of deoxycytidine. It is used clinically to treat patients with non-small-cell lung cancer (NSCLC). Curcumin is a yellow pigment derived from the rhizome of Curcuma longa, and has been proven to have antioxidant and antitumor properties. Human MutS homolog 2 (MSH2) is a ... Read More»

Jen-Chung Ko, Yi-Shuan Peng, Chia-Hung Wu, Jyh-Cheng Chen, Hao-Yu Zheng, Yuan-Cheng Lin, Peng-Fang Ma, Wen-Ching Chen and Yun-Wei Lin

Review Article: Epidemiology (Sunnyvale) 2017, 7: 332

DOI: 10.4172/2161-1165.1000332

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Relevant Topics
Top